Mylan in the UK was originally founded, in 1981, as Generics [UK] Limited. The company rapidly grew into a leading generic pharmaceutical supplier of high quality low cost products encompassing all the major therapeutic classes and became part of the generics business of Merck KGaA in 1994.
Generics [UK] Limited was purchased by Mylan in October 2007 and on November 4th, rebranded to Mylan to complete the transition of becoming part of a global company infrastructure that offers increased portfolio development opportunities and supply chain efficiency, helping us to achieve our goal of becoming the preferred supplier in the UK.
Mylan in the UK is a leading developer and supplier of generic medicines with a growing portfolio of over 350 products sold to retailers and wholesalers and throughout the National Health Service.
Mylan is committed to being the preferred generic pharmaceutical supplier in the UK by continuously developing and marketing a broad product portfolio of quality, affordable generic and speciality medicines, whilst maintaining an industry leading supply and customer service level.
Mylan Inc., our ultimate parent company, ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies. For more information, please visit www.mylan.com.
(Last Updated: 03-11-2009)